As part of Springer Nature’s range of offerings to the scientific world, the Nature Portfolio webcasts programme presents live and on-demand webcasts across the life, physical, chemical and ...

(Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and ...